Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by lscfaon Feb 07, 2021 8:53pm
131 Views
Post# 32497601

RE:Post Covid19 Revenue Numbers

RE:Post Covid19 Revenue NumbersUse diluted share no.s. since all Wrts/options are in the money....


 

Shs sept 30

149,440,109

 

Jan pp Shs

20,000,000

 

Jan broker Shs

276,800

 

Jan broker unit wrts

1,160,000

 

 

170,876,909

 

 

 

 

Warrants sev30

16,050,000

$0.25 Avg price

Jan pp Wrts

10,000,000

Strike $0.4

Jan broker Wrts

276,800

 

Jan Broker unit wrts

580,000

For 1 unit @ $0.20

 

26,906,800

 

 

 

 

Options se 30

11,563,000

$0.17 avg price

 

 

 

Diluted shs o/s

209,346,709

 

 








Hiddensecrets wrote: The question arises as to what type of revenu numbers can we expect post covid19.    

Keep in mind that WHO has stated that the covid19 will become endemic, meaning with us forever. 

There will remain a need for testing for many reasons post covid19:
-- to test for your antibodies - which is ensuring that you are still protected 
- to test if you are positive or negative with antigen - if you no longer have the antibodies
- to test if vaccine is protecting against the various variants

The reason for continued testing is that you have to make sure that covid19 stays under control and does not resurface as it has caused monumental monetary and emotional damage. 

I will presume very conservative numbers:


We will assume that MEDV keeps 50 cubes in the future ongoing year to year.   

And we will assume that each cube does 40 tests per day, which means each cube does 1,200 tests per month or, 14,400 tests per year. 

Think of it another way, a city with 150,000 persons would mean 10% of its people get tested in one year, on and off, which is reasonable.

I assume tests will sell at an average of $ 96 USD per year.

That means recurring revenue for many years of:   $ 70,080,000 per year 

Margin rates will remain at 55% as it is high profit. 

This means earnings of:   $ 38,544,000

Earnings per share:        .23 cents per share

I have not included anything else that MEDV is doing.    

So this begs the question, how much should a company be valued at when it will earn 23 cents per share on a yearly basis for many years, without accounting for anything else?

MPO


<< Previous
Bullboard Posts
Next >>